Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Molecular Burglary: Cancer Cells Hijack Energy from Immune Cells

Ogkologos - 21 Νοεμβρίου, 2023

Efficacy Outcomes of Olaparib in Patients with mCRPC with BRCA Alterations...

Ogkologos - 21 Νοεμβρίου, 2023

How to Talk About Advanced Cancer Care Planning: An Expert Discussion

Ogkologos - 20 Νοεμβρίου, 2023

FDA Approves Fruquintinib for Patients with Refractory Metastatic Colorectal Cancer

Ogkologos - 20 Νοεμβρίου, 2023

FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction...

Ogkologos - 17 Νοεμβρίου, 2023

EMA Recommends Granting a Conditional Marketing Authorisation for Adagrasib Following a Re-Examination...

Ogkologos - 17 Νοεμβρίου, 2023

Spotlight On: Exercise Physiologists in Cancer Care

Ogkologos - 16 Νοεμβρίου, 2023

Adjuvant Atezolizumab Plus Bevacizumab Improves RFS Among Patients at High Risk...

Ogkologos - 16 Νοεμβρίου, 2023

Selpercatinib Slows Progression of RET-Positive Lung, Medullary Thyroid Cancers

Ogkologos - 15 Νοεμβρίου, 2023

Severe Immune-Related Gastroenterocolitis Described After in Utero Exposure to Pembrolizumab

Ogkologos - 15 Νοεμβρίου, 2023

1...102103104...440 Σελίδα 103 από 440

MOST POPULAR

Osteoblasts Are “Warrior” Bone Cells That Can Suppress Bone-Metastatic Breast Cancer...

10 Ιουνίου, 2019

FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory B-Cell Precursor Acute...

7 Οκτωβρίου, 2021

Drug Combo JAKs Up Immunotherapy in Two Clinical Trials

8 Αυγούστου, 2024

Researchers Discover Way to Help Immunotherapy Better Target Solid Tumors Like...

5 Ιανουαρίου, 2021

Φόρτωση περισσοτέρων

Molecular Burglary: Cancer Cells Hijack Energy from Immune Cells

Efficacy Outcomes of Olaparib in Patients with mCRPC with BRCA Alterations...

How to Talk About Advanced Cancer Care Planning: An Expert Discussion

FDA Approves Fruquintinib for Patients with Refractory Metastatic Colorectal Cancer

FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction...

EMA Recommends Granting a Conditional Marketing Authorisation for Adagrasib Following a Re-Examination...

Spotlight On: Exercise Physiologists in Cancer Care

Adjuvant Atezolizumab Plus Bevacizumab Improves RFS Among Patients at High Risk...

Selpercatinib Slows Progression of RET-Positive Lung, Medullary Thyroid Cancers

Severe Immune-Related Gastroenterocolitis Described After in Utero Exposure to Pembrolizumab

MOST POPULAR

Osteoblasts Are “Warrior” Bone Cells That Can Suppress Bone-Metastatic Breast Cancer...

FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory B-Cell Precursor Acute...

Drug Combo JAKs Up Immunotherapy in Two Clinical Trials

Researchers Discover Way to Help Immunotherapy Better Target Solid Tumors Like...

HOT NEWS

EMA Recommends Extending Indications for Lisocabtagene Maraleucel

Sacituzumab Govitecan Approved for Metastatic Triple-Negative Breast Cancer

Julia Louis-Dreyfus Talks About The Side Effects of Chemotherapy

Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ